Sign in to your account
or
By signing in you agree to our
Terms & conditions
 and 
Privacy policy
Kanchan Vats
linkedin

Kanchan Vats

B.Pharm, M.Pharm
Tata 1mg | Team Lead, Medical Affairs
8 Years Experience
About
Kanchan Vats is working as a team lead in the medical affairs team. Kanchan did her masters in Pharmacology and Toxicology MS(Pharm) from one of the reputed institutes of India, National Institute Of Pharmaceutical Education & Research (NIPER), Ahmedabad. She has qualified two national level exams, i.e., NIPER JEE and Graduate Pharmacy Aptitude Test (GPAT). She was associated with Training and Development team for more than 3 years with Intas Pharmaceuticals Pvt. Limited, Ahmedabad. She was awarded as the "best team award" during COVID in Intas. During her masters, she has extensively worked on stroke and published almost 9 articles in reputed journals.
Qualifications and Experience
Education
M.Pharm | National Institute Of Pharmaceutical Education and Research (NIPER), Ahmedabad | 2016 - 2018External link
B.Pharm | Abdul Kalam Technical University (AKTU), Uttar Pradesh | 2012 - 2016External link
Experience
Intas Pharmaceuticals Limited, Ahmedabad | Senior Executive | 2018 - 2021External link
Tata 1mg | Team Lead, Medical AffairsExternal link
Research Publications
Intra-arterial Stem Cell Therapy Diminishes Inflammasome Activation After Ischemic Stroke: a Possible Role of Acid Sensing Ion Channel 1a.publication
Inflammasomes in stroke: a triggering role for acid-sensing ion channels.publication
Mitochondrial Dysfunction in Stroke: Implications of Stem Cell Therapy.publication
Intra-arterial stem cell therapy modulates neuronal calcineurin and confers neuroprotection after ischemic stroke.publication
Trigonelline therapy confers neuroprotection by reduced glutathione mediated myeloperoxidase expression in animal model of ischemic stroke.publication
Noncoding RNAs in ischemic stroke: time to translate.publication
Inflammasome Mediated Reduction of Myeloperoxidase in Ischemic Stroke by Intra-arterial Mesenchymal Stem Cell Therapy.publication
Intra-arterial mesenchymal stem cell therapy modulates inflammasome to confer neuroprotection in animal model of ischemic stroke.publication
Intra-Arterial Mesenchymal Stem Cell Therapy Modulates Expression of NLRP1 Inflammasome in Animal Model of Ischemic Strokepublication